Does OBINUTUZUMAB Cause Agranulocytosis? 98 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 98 reports of Agranulocytosis have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.7% of all adverse event reports for OBINUTUZUMAB.
98
Reports of Agranulocytosis with OBINUTUZUMAB
0.7%
of all OBINUTUZUMAB reports
2
Deaths
45
Hospitalizations
How Dangerous Is Agranulocytosis From OBINUTUZUMAB?
Of the 98 reports, 2 (2.0%) resulted in death, 45 (45.9%) required hospitalization, and 5 (5.1%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
Yes, Agranulocytosis is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which OBINUTUZUMAB Alternatives Have Lower Agranulocytosis Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE